索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]周任,赵强.超声心动图在肥厚型心肌病诊断与评估中的应用进展[J].国际心血管病杂志,2016,05:276-279.
点击复制

超声心动图在肥厚型心肌病诊断与评估中的应用进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2016年05期
页码:
276-279
栏目:
综述
出版日期:
2016-09-20

文章信息/Info

Title:
-
作者:
周任; 赵强
200025 上海交通大学医学院附属瑞金医院心脏外科
Author(s):
-
关键词:
肥厚型心肌病; 超声心动图; 诊断
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2016.05.006
文献标识码:
-
摘要:
肥厚型心肌病是以心肌肥厚为特征的原发性心肌病。典型的病理表现为室间隔和左心室游离壁非对称性肥厚,常导致劳力性左心室流出道梗阻。患者的表现为呼吸困难、胸痛、心悸、头晕、黑朦甚至昏厥,为青壮年猝死的主要原因之一。超声心动图作为早期诊断肥厚型心肌病首选的无创方法近年取得较大进展。该文介绍超声心动图在评估心肌肥厚程度、二尖瓣功能、左室流出道梗阻程度以及心脏收缩、舒张功能方面的进展。
Abstract:
-

参考文献/References

[1] Maron BJ,Ommen SR,Semsarian C,et al. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine [J]. J Am Coll Cardiol, 2014, 64(1): 83-99.
[2] Hensley N,Dietrich J,Nyhan D,et al. Hypertrophic cardiomyopathy: a review [J]. Anesth Analg, 2015, 120(3): 554-569.
[3] Maron BJ,Maron MS. Hypertrophic cardiomyopathy [J]. Lancet, 2013, 381(9862): 242-255.
[4] Elliott PM,Anastasakis A,Borger MA,et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology(ESC)[J]. Eur Heart J, 2014, 35(39): 2733-2779.
[5] Jiang H,Ge J. Epidemiology and clinical management of cardiomyopathies and heart failure in China [J]. Heart, 2009, 95(21): 1727-1731.
[6] Semsarian C,Ingles J,Maron MS,et al. New perspectives on the prevalence of hypertrophic cardiomyopathy [J]. J Am Coll Cardiol, 2015, 65(12): 1249-1254.
[7] 王颍骅,薛 松. 肥厚型梗阻性心肌病的外科治疗 [J]. 国际心血管病杂志, 2014, 41(5): 324-326.
[8] Gersh BJ,Maron BJ,Bonow RO,et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J]. J Thorac Cardiovasc Surg, 2011, 142(6): e153-203.
[9] Maron MS,Hauser TH,Dubrow E,et al. Right ventricular involvement in hypertrophic cardiomyopathy [J]. Am J Cardiol, 2007, 100(8): 1293-1298.
[10] Spirito P,Bellone P,Harris KM,et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy [J]. N Engl J Med, 2000, 342(24): 1778-1785.
[11] Guo X,Fan C,Wang H,et al. The prevalence and long-term outcomes of extreme right versus extreme left ventricular hypertrophic cardiomyopathy [J]. Cardiology, 2016, 133(1): 35-43.
[12] Pantazis A,Vischer AS,Perez-Tome MC,et al. Diagnosis and management of hypertrophic cardiomyopathy [J]. Echo Res Pract, 2015, 2(1): R45-53.
[13] Walpot J,Pasteuning WH,Shivalkar B. Apical hypertrophic cardiomyopathy: elegant use of contrast-enhanced echocardiography in the diagnostic work-up [J]. Acta Cardiol, 2012, 67(4): 495-497.
[14] Parisi R,Mirabella F,Secco GG,et al. Multimodality imaging in apical hypertrophic cardiomyopathy [J]. World J Cardiol, 2014, 6(9): 916-923.
[15] Weissler-Snir A,Crean A,Rakowski H. The role of imaging in the diagnosis and management of hypertrophic cardiomyopathy [J]. Expert Rev Cardiovasc Ther, 2016, 14(1): 51-74.
[16] Patil PV,Wiegers SE. Echocardiography for hypertrophic cardiomyopathy [J]. Prog Cardiovasc Dis, 2014, 57(1): 91-99.
[17] Pandian NG,Rowin EJ,Gonzalez AM,et al. Echocardiographic profiles in hypertrophic cardiomyopathy: imaging beyond the septum and systolic anterior motion [J]. Echo Res Pract, 2015, 2(1): E1-7.
[18] Williams LK,Gruner CH,Rakowski H. The role of echocardiography in hypertrophic cardiomyopathy [J]. Curr Cardiol Rep, 2015, 17(2): 560-566.
[19] Cavalcante JL,Barboza JS,Lever HM. Diversity of mitral valve abnormalities in obstructive hypertrophic cardiomyopathy [J]. Prog Cardiovasc Dis, 2012, 54(6): 517-522.
[20] Kim DH,Handschumacher MD,Levine RA,et al. In vivo measurement of mitral leaflet surface area and subvalvular geometry in patients with asymmetrical septal hypertrophy: insights into the mechanism of outflow tract obstruction [J]. Circulation, 2010, 122(13): 1298-1307.
[21] Joshi S,Patel UK,Yao SS,et al. Standing and exercise Doppler echocardiography in obstructive hypertrophic cardiomyopathy: the range of gradients with upright activity [J]. J Am Soc Echocardiogr, 2011, 24(1): 75-82.
[22] Peteiro J,Bouzas-Mosquera A,Fernandez X,et al. Prognostic value of exercise echocardiography in patients with hypertrophic cardiomyopathy [J]. J Am Soc Echocardiogr, 2012, 25(2): 182-189.
[23] Morise AP. Exercise testing in nonatherosclerotic heart disease: hypertrophic cardiomyopathy, valvular heart disease, and arrhythmias [J]. Circulation, 2011, 123(2): 216-225.
[24] Badran HM,Ibrahim WA,Faheem N,et al. Provocation of left ventricular outflow tract obstruction using nitrate inhalation in hypertrophic cardiomyopathy: Relation to electromechanical delay [J]. Glob Cardiol Sci Pract, 2015,(15): 11.
[25] Yalcin F,Yigit F,Erol T,et al. Effect of dobutamine stress on basal septal tissue dynamics in hypertensive patients with basal septal hypertrophy [J]. J Hum Hypertens, 2006, 20(8): 628-630.
[26] Roldan FJ,Vargas-Barron J,Espinola-Zavaleta N,et al. Severe dynamic obstruction of the left ventricular outflow tract induced by dobutamine [J]. Echocardiography, 2000, 17(1): 37-40.
[27] Harris KM,Spirito P,Maron MS,et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy [J]. Circulation, 2006, 114(3): 216-225.
[28] Weidemann F,Stork S,Liu D,et al. Cardiomyopathy of Friedreich ataxia [J]. J Neurochem, 2013, 126(S1): 88-93.
[29] Nagueh SF,Bierig SM,Budoff MJ,et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography [J]. J Am Soc Echocardiogr, 2011, 24(5): 473-498.
[30] Maciver DH. A new method for quantification of left ventricular systolic function using a corrected ejection fraction [J]. Eur J Echocardiogr, 2011, 12(3): 228-234.
[31] Smiseth OA,Torp H,Opdahl A,et al. Myocardial strain imaging: how useful is it in clinical decision making? [J]. Eur Heart J, 2015, 37(15): 1196-1207,
[32] Kalam K,Otahal P,Marwick TH. Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction [J]. Heart, 2014, 100(21): 1673-1680.
[33] Haland TF,Almaas VM,Hasselberg NE,et al. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy [J]. Eur Heart J Cardiovasc Imaging, 2016, 17(6): 613-621,
[34] Nagueh SF,Appleton CP,Gillebert TC,et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography [J]. J Am Soc Echocardiogr, 2009, 22(2): 107-133.
[35] Saito M,Okayama H,Yoshii T,et al. The differences in left ventricular torsional behavior between patients with hypertrophic cardiomyopathy and hypertensive heart disease [J]. Int J Cardiol, 2011, 150(3): 301-306.
[36] Shetty R,Samanth J,Nayak K,et al. Evaluation of subtle left ventricular systolic abnormalities in adult patients with hypertrophic cardiomyopathy [J]. J Clin Diagn Res, 2014, 8(12): MC05-09.

备注/Memo

备注/Memo:
通信作者:赵 强,Email:zq11607@rjh.com.cn
更新日期/Last Update: 2016-09-20